What is CVE-2026-13094?

CVE-2026-13094 is a high-severity vulnerability in Ibm I Access Client Solutions, classified under Code Injection. CVSS score: 7.8/10. Published 2026-08-12.

How severe is CVE-2026-13094?

High severity. CVSS v3 base score is 7.8 out of 10.

RCE in Ibm I Access Client Solutions

CVE-2026-13094

IBM i Access Client Solutions 1.1.2.0 through 1.1.9.13 is vulnerable to arbitrary code execution on Windows when installed for all users due to publicly writeable configuration file.

Vulnerability class: RCE (Remote Code Execution)

CVSS v3 metric

CVSS v3 base score 7.8 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.

Affected products

Ibm I Access Client Solutions — versions 1.1.2.0

Weakness classification (CWE)

CWE-94 — Code Injection

References

psirt@us.ibm.com (vendor-advisory, patch)

Frequently asked questions

What is CVE-2026-13094?: CVE-2026-13094 is a high-severity vulnerability in Ibm I Access Client Solutions, classified under Code Injection. CVSS score: 7.8/10. Published 2026-08-12.
How severe is CVE-2026-13094?: High severity. CVSS v3 base score is 7.8 out of 10.